Want to join the conversation?
$LLY said John Lechleiter will continue on its BoD until May 31, 2017, serving as non-executive chairman, at which time he will leave the board. $LLY's BoD unanimously elected David Ricks, currently SVP and president, Lilly Bio-Medicines, to assume role of president and CEO and to join board on Jan. 1, 2017, and to become chairman on June 1, 2017.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?